Financial results - ANDREDY PHARMA-SAN SRL

Financial Summary - Andredy Pharma-San Srl
Unique identification code: 26756084
Registration number: J2010000228324
Nace: 4773
Sales - Ron
693.909
Net Profit - Ron
80.736
Employees
4
Open Account
Company Andredy Pharma-San Srl with Fiscal Code 26756084 recorded a turnover of 2024 of 693.909, with a net profit of 80.736 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Andredy Pharma-San Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 544.040 505.133 529.758 546.363 543.092 594.130 580.644 649.575 680.568 693.909
Total Income - EUR 544.118 507.362 530.055 546.623 546.164 594.140 582.710 656.007 681.021 698.750
Total Expenses - EUR 495.834 460.579 465.780 471.372 476.821 502.532 495.031 575.181 599.817 604.248
Gross Profit/Loss - EUR 48.284 46.783 64.274 75.251 69.343 91.608 87.679 80.827 81.204 94.502
Net Profit/Loss - EUR 41.146 40.523 55.172 69.747 63.865 86.287 82.867 75.199 73.297 80.736
Employees 7 6 7 6 6 5 5 5 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 2.5%, from 680.568 euro in the year 2023, to 693.909 euro in 2024. The Net Profit increased by 7.849 euro, from 73.297 euro in 2023, to 80.736 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Andredy Pharma-San Srl

Rating financiar

Financial Rating -
ANDREDY PHARMA-SAN SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Andredy Pharma-San Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Andredy Pharma-San Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Andredy Pharma-San Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Andredy Pharma-San Srl - CUI 26756084

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 28.761 30.490 21.666 13.433 20.713 15.623 27.870 45.508 30.395 16.608
Current Assets 128.778 103.991 127.723 144.321 113.245 167.854 197.850 253.193 267.482 285.736
Inventories 43.592 42.935 32.567 29.283 37.942 45.672 36.029 44.654 41.837 42.759
Receivables 42.140 17.089 50.670 59.460 56.037 78.311 89.206 161.743 108.345 100.628
Cash 43.046 43.966 44.486 55.578 19.266 43.871 72.615 46.796 115.876 21.851
Shareholders Funds 41.191 40.568 55.216 69.790 63.907 86.328 113.731 75.248 73.346 80.785
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 118.701 94.758 94.578 88.323 70.392 97.432 112.283 224.077 225.231 222.251
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 285.736 euro in 2024 which includes Inventories of 42.759 euro, Receivables of 100.628 euro and cash availability of 21.851 euro.
The company's Equity was valued at 80.785 euro, while total Liabilities amounted to 222.251 euro. Equity increased by 7.849 euro, from 73.346 euro in 2023, to 80.785 in 2024.

Risk Reports Prices

Reviews - Andredy Pharma-San Srl

Comments - Andredy Pharma-San Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.